DE69132944D1 - Azolederivate als Inhibitor von Superoxide-Radikalen - Google Patents

Azolederivate als Inhibitor von Superoxide-Radikalen

Info

Publication number
DE69132944D1
DE69132944D1 DE69132944T DE69132944T DE69132944D1 DE 69132944 D1 DE69132944 D1 DE 69132944D1 DE 69132944 T DE69132944 T DE 69132944T DE 69132944 T DE69132944 T DE 69132944T DE 69132944 D1 DE69132944 D1 DE 69132944D1
Authority
DE
Germany
Prior art keywords
inhibitors
azole derivatives
superoxide radicals
superoxide
radicals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69132944T
Other languages
English (en)
Other versions
DE69132944T2 (de
Inventor
Masatoshi Chihiro
Hajime Komatsu
Michiaki Tominaga
Yoichi Yabuuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69132944D1 publication Critical patent/DE69132944D1/de
Publication of DE69132944T2 publication Critical patent/DE69132944T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
DE69132944T 1990-11-30 1991-11-29 Azolederivate als Inhibitor von Superoxide-Radikalen Expired - Lifetime DE69132944T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33772790 1990-11-30

Publications (2)

Publication Number Publication Date
DE69132944D1 true DE69132944D1 (de) 2002-04-04
DE69132944T2 DE69132944T2 (de) 2002-11-21

Family

ID=18311399

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69132944T Expired - Lifetime DE69132944T2 (de) 1990-11-30 1991-11-29 Azolederivate als Inhibitor von Superoxide-Radikalen
DE69133471T Expired - Lifetime DE69133471T2 (de) 1990-11-30 1991-11-29 Azolderivate und ihre Verwendung als Inhibitoren von Superoxidradikalen
DE69132006T Expired - Lifetime DE69132006T2 (de) 1990-11-30 1991-11-29 Thiazolederivate als inhibitoren von aktivem sauerstoff

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE69133471T Expired - Lifetime DE69133471T2 (de) 1990-11-30 1991-11-29 Azolderivate und ihre Verwendung als Inhibitoren von Superoxidradikalen
DE69132006T Expired - Lifetime DE69132006T2 (de) 1990-11-30 1991-11-29 Thiazolederivate als inhibitoren von aktivem sauerstoff

Country Status (11)

Country Link
US (4) US5643932A (de)
EP (3) EP0934937B1 (de)
JP (2) JP2829451B2 (de)
KR (2) KR100195433B1 (de)
CA (3) CA2547947C (de)
DE (3) DE69132944T2 (de)
DK (3) DK0513387T3 (de)
ES (3) ES2144403T3 (de)
HK (1) HK1003938A1 (de)
TW (1) TW311136B (de)
WO (1) WO1992009586A1 (de)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU657413C (en) * 1992-05-29 2007-05-03 Otsuka Pharmaceutical Co., Ltd. Thiazole derivatives for the release of superoxide radical
US5639770A (en) * 1992-05-29 1997-06-17 Otsuka Pharmaceutical Co., Ltd. Thiazole derivatives
CA2144545A1 (en) * 1992-09-14 1994-03-31 Kiyoshi Iwaoka Novel condensed thiazole derivative, production process thereof and pharmaceutical composition thereof
WO1994017077A1 (en) * 1993-01-19 1994-08-04 Shiseido Company, Ltd. Active oxygen inhibitor composition
CN1143364A (zh) * 1994-03-11 1997-02-19 山之内制药株式会社 5-ht3受体激动剂、新颖的噻唑衍生物及其中间体
JPH10504542A (ja) * 1994-07-27 1998-05-06 ジー．ディー．サール アンド カンパニー 炎症処置用の置換チアゾール化合物
US6696459B1 (en) 1994-12-22 2004-02-24 Ligand Pharmaceuticals Inc. Steroid receptor modulator compounds and methods
US5688810A (en) 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
EP1382597A3 (de) * 1994-12-22 2004-04-07 Ligand Pharmaceuticals, Inc. Steroidrezeptor-Modulator Verbindungen und Methoden
JP3896552B2 (ja) * 1996-03-25 2007-03-22 大塚製薬株式会社 チアゾール誘導体−金属錯体
AU4298997A (en) * 1996-08-26 1998-03-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Thiazole derivatives useful as selective inhibitors of pde-iv
PT920426E (pt) * 1996-08-26 2004-02-27 Altana Pharma Ag Novos derivados de tiazole com efeito inibidor de fosfodiesterase
MY128323A (en) * 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
JP4305662B2 (ja) * 1996-09-30 2009-07-29 大塚製薬株式会社 サイトカイン産生抑制剤及び接着抑制剤
JP4305668B2 (ja) * 1996-09-30 2009-07-29 大塚製薬株式会社 サイトカイン異常産生又は接着作用の亢進に伴う疾患を予防又は治療するための薬剤
JP4300373B2 (ja) * 1996-09-30 2009-07-22 大塚製薬株式会社 サイトカイン産生抑制剤及び接着抑制剤
US6043263A (en) * 1996-11-12 2000-03-28 Byk Gulden Lomberg Chemische Fabrik Gmbh (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
AU6645998A (en) * 1996-12-23 1998-07-17 Du Pont Pharmaceuticals Company Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
US6187797B1 (en) 1996-12-23 2001-02-13 Dupont Pharmaceuticals Company Phenyl-isoxazoles as factor XA Inhibitors
ZA985251B (en) 1997-06-19 1999-12-17 Du Pont Merck Pharma Inhibitors of factor Xa with a neutral P1 specificity group.
PL337831A1 (en) * 1997-06-19 2000-09-11 Du Pont Pharm Co Inhibitors of factor xa containing a specificity giving p1 group
US5998424A (en) 1997-06-19 1999-12-07 Dupont Pharmaceuticals Company Inhibitors of factor Xa with a neutral P1 specificity group
US6339099B1 (en) 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
US5886191A (en) * 1997-08-18 1999-03-23 Dupont Pharmaceuticals Company Amidinoindoles, amidinoazoles, and analogs thereof
AU9648098A (en) * 1997-10-27 1999-05-17 Takeda Chemical Industries Ltd. Adenosine a3 receptor antagonists
PL341984A1 (en) 1998-01-28 2001-05-07 Shionogi & Co Novel tricycle compounds
DE19816880A1 (de) * 1998-04-17 1999-10-21 Boehringer Ingelheim Pharma Neue Diphenyl-substituierte 5-Ring-Heterocyclen, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
US6322449B1 (en) 1998-02-04 2001-11-27 Klitsner Industrial Design, Llc Mechanical interface device
HUP0102470A3 (en) 1998-07-01 2002-05-28 Takeda Chemical Industries Ltd 1,3-azole derivatives as retinoid-associated receptor regulators and their use
US6083966A (en) * 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
EP1143951A3 (de) * 1998-09-21 2002-02-06 University Of Florida Research Foundation, Inc. Mittel gegen malaria
JP4336913B2 (ja) * 1999-02-12 2009-09-30 大塚製薬株式会社 アミド誘導体の製造方法
JP2000281664A (ja) * 1999-03-30 2000-10-10 Otsuka Pharmaceut Co Ltd チアゾール誘導体
ES2197092T3 (es) 1999-04-02 2004-01-01 Bristol-Myers Squibb Pharma Company Sulfonil arilos como inhibidores del factor xa.
EP1652839A3 (de) * 1999-10-28 2006-07-05 Daiichi Pharmaceutical Co., Ltd. Pumpeninhibitoren zur Freisetzung von Medikamenten
JP2001131151A (ja) * 1999-11-02 2001-05-15 Shionogi & Co Ltd オレフィン誘導体の新規用途
HUP0302167A3 (en) * 2000-10-02 2010-03-29 Janssen Pharmaceutica Nv Quinoline derivatives as metabotropic glutamate receptor antagonists, pharmaceutical compositions containing them and process for producing them
JP4160295B2 (ja) * 2000-12-08 2008-10-01 武田薬品工業株式会社 ３−ピリジル基を有する置換チアゾール誘導体、その製造法および用途
DE10102084B4 (de) * 2001-01-18 2006-06-29 Wella Ag 1,4-Diamino-2-(thiazol-2-yl)-benzol-Derivate enthaltende Haarfärbemittel
JPWO2002087589A1 (ja) * 2001-04-26 2004-08-12 第一製薬株式会社 薬剤排出ポンプ阻害薬
US7056917B2 (en) * 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
ES2249596T3 (es) 2001-07-24 2006-04-01 Otsuka Pharmaceutical Co., Ltd. Utilizacion de derivados de tiazol para la fabricacion de un medicamento para el tratamiento de la bronconeumopatia cronica obstructiva.
US8124625B2 (en) 2001-09-14 2012-02-28 Shionogi & Co., Ltd. Method of enhancing the expression of apolipoprotein AI using olefin derivatives
CA2469228A1 (en) * 2001-12-03 2003-06-12 Japan Tobacco Inc. Azole compound and medicinal use thereof
FR2835254B1 (fr) * 2002-01-25 2006-04-07 Sod Conseils Rech Applic Derives de thiazoles dans le traitement de maladies neurologiques
US6822097B1 (en) * 2002-02-07 2004-11-23 Amgen, Inc. Compounds and methods of uses
TWI314928B (en) 2002-02-28 2009-09-21 Novartis A 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
AU2003291613B2 (en) * 2002-04-30 2007-09-27 Merck & Co., Inc. Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers
JP2005530800A (ja) * 2002-05-15 2005-10-13 スミスクライン・ビーチャム・コーポレイション ベンゾオキサジンおよびベンゾオキサジノン置換トリアゾール
US20040044220A1 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
AU2003263948A1 (en) * 2002-08-22 2004-03-11 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
DE20301728U1 (de) 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
US20040147561A1 (en) * 2002-12-27 2004-07-29 Wenge Zhong Pyrid-2-one derivatives and methods of use
BRPI0409136A (pt) * 2003-04-09 2006-04-25 Japan Tobacco Inc composto heteroaromático pentacìclico e uso medicinal do mesmo
TW200503700A (en) * 2003-07-17 2005-02-01 Otsuka Pharma Co Ltd Enema preparation
WO2005034949A1 (en) * 2003-09-09 2005-04-21 University Of Florida Desferrithiocin derivatives and their use as iron chelators
US7820704B2 (en) * 2004-04-20 2010-10-26 Transtech Pharma, Inc. Substituted heteroaryl derivatives, compositions, and methods of use
EP1748044A4 (de) 2004-05-17 2007-12-12 Otsuka Pharma Co Ltd Thiazolverbindung und deren verwendung
TR201910900T4 (tr) 2005-04-04 2019-08-21 Univ Florida Desferritiyokin polieter analogları.
JP5222561B2 (ja) * 2005-10-07 2013-06-26 キッセイ薬品工業株式会社 含窒素芳香族複素環化合物およびそれを含有する医薬組成物
CA2635541A1 (en) * 2005-12-28 2007-07-12 Takeda Pharmaceutical Company Limited Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
TWI394753B (zh) * 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd 新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體
TW200815054A (en) 2006-06-19 2008-04-01 Otsuka Pharma Co Ltd Methods of using a thiazole derivative
RS53461B (en) 2006-07-05 2014-12-31 Takeda Gmbh COMBINATION OF HMG-COA REDUCTASE INHIBITOR OR SIMVASTATIN WITH PHOSPHODIESTERASE 4 INHIBITOR AS A ROFLUMILAST FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASES
US7538107B2 (en) 2006-08-15 2009-05-26 Wyeth Oxazinan-2-one derivatives useful as PR modulators
TW200815428A (en) 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
US7618989B2 (en) 2006-08-15 2009-11-17 Wyeth Tricyclic oxazolidone derivatives useful as PR modulators
US7652018B2 (en) 2006-08-15 2010-01-26 Wyeth Llc Imidazolidin-2-one derivatives useful as PR modulators
US7649007B2 (en) 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
US9085566B2 (en) 2007-02-02 2015-07-21 Baylor College Of Medicine Compositions and methods for the treatment of metabolic and related disorders
US9233941B2 (en) 2007-02-02 2016-01-12 Baylor College Of Medicine Methods and compositions for the treatment of body weight related disorders
US9212179B2 (en) 2007-02-02 2015-12-15 Baylor College Of Medicine Compositions and methods for the treatment of metabolic disorders
US9187485B2 (en) 2007-02-02 2015-11-17 Baylor College Of Medicine Methods and compositions for the treatment of cancer and related hyperproliferative disorders
EP2120580B1 (de) * 2007-02-02 2017-12-27 Baylor College Of Medicine Zusammensetzungen und verfahren zur behandlung von stoffwechselerkrankungen
NZ579994A (en) 2007-03-15 2011-09-30 Univ Florida Desferrithiocin polyether analogues useful in the treatment of pathological conditions responsive to chelation or sequestration of trivalent metal
HUE036519T2 (hu) 2007-08-13 2018-07-30 Monsanto Technology Llc Készítmények és eljárások nematódák irtására
WO2009033033A2 (en) * 2007-09-06 2009-03-12 Boston Biomedical, Inc. Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
KR20170128623A (ko) 2008-06-16 2017-11-22 유니버시티 오브 테네시 리서치 파운데이션 암 치료용 화합물
US8822513B2 (en) 2010-03-01 2014-09-02 Gtx, Inc. Compounds for treatment of cancer
US9029408B2 (en) 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
US8563742B2 (en) * 2008-08-29 2013-10-22 High Point Pharmaceuticals, Llc Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
WO2010042998A1 (en) 2008-10-17 2010-04-22 Akaal Pharma Pty Ltd S1p receptors modulators
CN102186845B (zh) 2008-10-17 2016-09-07 阿卡制药有限公司 S1p受体调节剂以及它们的用途
WO2011109059A1 (en) 2010-03-01 2011-09-09 Gtx, Inc. Compounds for treatment of cancer
WO2012172438A2 (en) * 2011-06-07 2012-12-20 Dynamix Pharmaceuticals Ltd. Compositions and methods for modulating a kinase
WO2012170371A1 (en) * 2011-06-10 2012-12-13 N30 Pharmaceuticals, Llc Compounds as s-nitrosoglutathione reductase inhibitors
MX368275B (es) 2011-12-16 2019-09-26 Univ Florida Usos de análogos de 4'-desferritiocina.
EP2888254B1 (de) * 2012-08-23 2016-10-05 The Institute of Cancer Research: Royal Cancer Hospital Kondensierte heterocyclische verbindungen und deren verwendung
WO2014074926A1 (en) * 2012-11-09 2014-05-15 Rutgers, The State University Of New Jersey Therapeutic hydroxyquinolones
CN109568312A (zh) 2013-03-05 2019-04-05 田纳西大学研究基金会 用于治疗癌症的化合物
WO2014158942A1 (en) * 2013-03-13 2014-10-02 Avon Products, Inc Compositions for improving the appearance of skin
AU2014312227A1 (en) * 2013-08-29 2016-04-21 Baylor College Of Medicine Compositions and methods for the treatment of metabolic and body weight related disorders
JP6838966B2 (ja) 2013-11-22 2021-03-03 ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． デスフェリチオシン類似体およびその使用
RU2017125663A (ru) 2014-12-19 2019-01-21 Галдерма Ресерч Энд Девелопмент Новые соединения, способ их синтеза и их применение в медицине, а также в косметике
KR20170140306A (ko) 2015-04-27 2017-12-20 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 대사적으로 프로그램화된 금속 킬레이트화제 및 그의 용도

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1970656A (en) * 1931-11-04 1934-08-21 Winthrop Chem Co Inc Thiazole compound and process of producing the same
NL284415A (de) * 1961-10-19
JPS3910130B1 (de) * 1962-05-10 1964-06-10
US3320270A (en) * 1963-10-08 1967-05-16 Tri Kem Corp Certain 2-acylimidothiazole compounds
GB1139940A (en) * 1966-09-30 1969-01-15 Ici Ltd Oxazole derivatives
US3401120A (en) * 1965-10-23 1968-09-10 Gaf Corp Corrosion inhibitors
DE1670383A1 (de) * 1966-09-14 1970-10-29 Ciba Geigy Neue Tetrahydroimidazole und Verfahren zu ihrer Herstellung
US3462448A (en) * 1966-10-27 1969-08-19 Dow Chemical Co Substituted phenyl thiazole compounds
IL28803A (en) * 1966-11-18 1974-05-16 Wyeth John & Brother Ltd Oxazole and thiazole compounds,their preparation and pharmaceutical compositions containing them
GB1226548A (de) * 1967-06-14 1971-03-31 Wyeth John & Brother Ltd
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3625999A (en) * 1968-02-19 1971-12-07 Lever Brothers Ltd Process for the preparation of phosphonium sulfonate salts
FR96117E (fr) * 1968-03-28 1972-05-19 Aquitaine Petrole Synthese d'oxazoles.
GB1262292A (en) * 1968-04-09 1972-02-02 Wyeth John & Brother Ltd Novel thiazoline derivatives, the preparation thereof and compositions containing the same
US4001420A (en) * 1968-12-12 1977-01-04 Science Union Et Cie, Societe Francaise De Recherche Medical Thiazolyl benzoic acid compounds
GB1248070A (en) * 1968-12-16 1971-09-29 Science Union & Cie Thiazolyl-benzoic acid derivatives and process for preparing them
US3635999A (en) 1969-03-25 1972-01-18 Aquitaine Petrole Synthesis of oxazoles
JPS4637822B1 (de) * 1969-05-31 1971-11-08
US3705153A (en) * 1969-05-14 1972-12-05 Sumitomo Chemical Co Novel thiazolyacetic acids and salts thereof
JPS4624696B1 (de) * 1969-06-30 1971-07-15
FR2082164A5 (en) * 1970-03-05 1971-12-10 Aries Robert Phenylalkyl esters of oxazolyl and thiazolyl carboxylic - acids - analgesics, antiinflammatories, tranquilisers
GB1308028A (en) * 1970-06-12 1973-02-21 Science Union & Cie Thiazolylbenzoic acid derivatives and a process for their manufactur
DE2048272C3 (de) * 1970-10-01 1974-10-17 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur Herstellung von 1,1,2-Trimethoxyäthanund o-Essigsäuremethylester
CA962269A (en) * 1971-05-05 1975-02-04 Robert E. Grahame (Jr.) Thiazoles, and their use as insecticides
GB1381860A (en) * 1971-06-03 1975-01-29 Wyeth John & Brother Ltd Tetrazole derivatives
JPS471469A (de) * 1971-06-22 1972-01-25
DE2152367C2 (de) * 1971-10-21 1985-01-03 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von 4- Methyl-oxazolen
BE791087A (fr) * 1971-11-15 1973-03-01 Lepetit Spa Oxazoles 2,4,5-trisubstitues et leur preparation
BE794096A (fr) * 1972-08-07 1973-05-16 Lepetit Spa Oxazoles 2,4,5-trisubstitues et leur preparation
JPS4938268A (de) * 1972-08-16 1974-04-09
JPS4938267A (de) * 1972-08-18 1974-04-09
JPS5327586B2 (de) * 1972-08-23 1978-08-09
JPS503315A (de) * 1973-05-10 1975-01-14
US4072689A (en) * 1973-02-22 1978-02-07 Gruppo Lepetit S.P.A. Monoamino 2,4,5-trisubstituted oxazoles
JPS5030619A (de) * 1973-07-23 1975-03-26
HU168036B (de) * 1973-11-09 1976-02-28
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4259341A (en) * 1977-06-01 1981-03-31 Merck & Co., Inc. Di- and tri-substituted thiazoles
US4153703A (en) * 1977-06-30 1979-05-08 Uniroyal, Inc. Method of controlling insects and acarids with certain aryl-substituted thiazoles
JPS5461936A (en) * 1977-10-26 1979-05-18 Ricoh Co Ltd Photoreceptor for electrophotography
JPS6051475B2 (ja) * 1977-11-08 1985-11-14 久光製薬株式会社 新規なフエニル酢酸誘導体
GB1574583A (en) * 1978-02-09 1980-09-10 Wyeth John & Brother Ltd Process for preparing thiazoles
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4221584A (en) * 1979-02-09 1980-09-09 Chevron Research Company Herbicidal and plant-growth-regulating N-(heterocyclyl)-methylacetanilides
JPS55111418A (en) * 1979-02-21 1980-08-28 Santen Pharmaceut Co Ltd Remedy for eye disease and its preparation
NZ193011A (en) * 1979-03-19 1983-03-15 Ici Australia Ltd Diarylamine derivatives intermediates herbicidal compositions
AU534093B2 (en) * 1979-03-19 1984-01-05 Ici Australia Limited Thiazoles,benzthiazoles, benzoxazoles and benzimidazoles
JPS55133366A (en) * 1979-04-05 1980-10-17 Otsuka Pharmaceut Factory Inc Thiazole derivative
US4298743A (en) * 1979-09-11 1981-11-03 Merck & Co., Inc. 4-(Substituted phenyl thiazolyl)-3-hydroxy-3-pyrroline-2,5-diones
JPS56123544A (en) * 1980-03-03 1981-09-28 Hitachi Ltd Composite type electrophotographic plate and electrophotographic method using it
US4322428A (en) * 1980-04-02 1982-03-30 Eli Lilly And Company 2(4-Fluorophenyl)-4,5,-bis(4-methoxyphenyl)thiazole and method of use
ZA811691B (en) * 1980-04-03 1982-10-27 Wyeth John & Brother Ltd Thiazoles
US4329459A (en) * 1980-05-05 1982-05-11 The Upjohn Company Tetrahydrobenzopyran derivatives
US4282364A (en) * 1980-05-22 1981-08-04 Merck & Co., Inc. Process for the preparation of thiazoles
JPS58120257A (ja) * 1982-01-12 1983-07-18 Hitachi Chem Co Ltd 電子写真感光体
DD204094A1 (de) * 1982-02-11 1983-11-16 Horst Hartmann Verfahren zur herstellung von 2-aryl-4-cumaryl-(3')- bzw. 2,4-bis-cumaryl-(3')-thiazolen
JPS58201771A (ja) * 1982-05-19 1983-11-24 Tanabe Seiyaku Co Ltd アルキルオキサゾリル酢酸誘導体
JPS58219169A (ja) * 1982-06-15 1983-12-20 Takeda Chem Ind Ltd オキサゾ−ル酢酸誘導体
JPS5925381A (ja) * 1982-06-30 1984-02-09 Hisamitsu Pharmaceut Co Inc 新規なフエニル酢酸誘導体
JPS5925380A (ja) * 1982-06-30 1984-02-09 Hisamitsu Pharmaceut Co Inc 新規なフエニル酢酸誘導体
US4659657A (en) * 1982-12-24 1987-04-21 Bayer Aktiengesellschaft Chromogenic and fluorogenic esters for photometric or fluorimetric determination of phosphatases or sulphatases
JPS6058981A (ja) * 1983-09-09 1985-04-05 Takeda Chem Ind Ltd ５−ピリジル−１，３−チアゾ−ル誘導体，その製造法およびそれを含んでなる医薬組成物
JPS6051111A (ja) * 1983-08-30 1985-03-22 Tanabe Seiyaku Co Ltd 抗脂血剤
JPS60151045A (ja) * 1984-01-19 1985-08-08 富士写真フイルム株式会社 感光材料用包装材料
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone
JPS6133186A (ja) * 1984-07-25 1986-02-17 Kanebo Ltd 新規なジフエニルピロリルチアゾ−ル誘導体、その製造法およびそれを有効成分とする医薬組成物
JPS61200985A (ja) * 1985-02-28 1986-09-05 Kanebo Ltd 新規なジフエニルピロリルチアゾ−ル誘導体、その製造法およびそれを有効成分とする医薬組成物
US4659726A (en) * 1984-04-19 1987-04-21 Kanebo, Ltd. Novel 4,5-Bis (4-methoxyphenyl)-2-(pyrrol-2-yl) thiazoles and pharmaceutical composition containing the same
JPS60222481A (ja) * 1984-04-19 1985-11-07 Kanebo Ltd 新規なジフエニルピロリルチアゾ−ル誘導体、その製造法およびそれを有効成分とする医薬組成物
JPS60230147A (ja) * 1984-04-27 1985-11-15 Ricoh Co Ltd 電子写真製版用印刷原版
DE3425118A1 (de) * 1984-07-07 1986-01-16 Boehringer Mannheim Gmbh, 6800 Mannheim Neue redox-indikatoren
JPS6123790A (ja) * 1984-07-12 1986-02-01 Hitachi Cable Ltd ＮｉまたはＮｉ合金表面へのメツキ方法
DE3501696A1 (de) * 1985-01-19 1986-07-24 Bayer Ag, 5090 Leverkusen Pyridopyrimidine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3525689C1 (de) * 1985-07-18 1986-10-30 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren und Einrichtung zum Betrieb eines mit einer Protonenuebertragungsreaktion arbeitenden Farbstoff-Lasers
CA1292226C (en) * 1986-01-16 1991-11-19 Terumi Hachiya Indenothiazole derivative and process for preparing the same
DE3601411A1 (de) * 1986-01-20 1987-07-23 Nattermann A & Cie 3-amino-1-(2-thiazolyl)-2-pyrazoline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
AU7301587A (en) * 1986-04-30 1987-11-24 Fmc Corporation Photoactive azole pesticides
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物
JPS63192755A (ja) * 1987-02-06 1988-08-10 Fujisawa Pharmaceut Co Ltd ２−フエニルアゾ−ル誘導体およびその塩
US4791200A (en) * 1987-06-22 1988-12-13 Ortho Pharmaceutical Corporation 2-substituted-4-aryl-substituted thiazoles
JPS6422861A (en) * 1987-07-18 1989-01-25 Kirin Brewery New substance ag55-2
MY104933A (en) * 1987-09-30 1994-07-30 Pfizer Ltd Platelet activating factor antagonists
JPH02171280A (ja) * 1988-12-26 1990-07-02 Agency Of Ind Science & Technol インクジェット用蛍光性インク組成物
DE3929233A1 (de) 1989-09-02 1991-03-07 Bayer Ag 5-heterocyclyl-pyridin-3-carbon-benzylamide und -anilide
AU621245B2 (en) * 1989-10-17 1992-03-05 Boehringer Mannheim Gmbh Hydrolase substrates, a process for the preparation thereof and agents containing them

Also Published As

Publication number Publication date
JP3182556B2 (ja) 2001-07-03
CA2547947A1 (en) 1992-06-25
EP0934937A1 (de) 1999-08-11
ES2173683T3 (es) 2002-10-16
JP2829451B2 (ja) 1998-11-25
EP0513387B1 (de) 2000-03-01
CA2396738A1 (en) 1992-06-25
DE69132944T2 (de) 2002-11-21
DE69133471D1 (de) 2005-07-21
KR100195433B1 (ko) 1999-06-15
US5677319A (en) 1997-10-14
EP0513387A4 (en) 1993-04-21
EP1130017A3 (de) 2001-09-19
US6080764A (en) 2000-06-27
EP0934937B1 (de) 2002-02-27
EP1130017A2 (de) 2001-09-05
AU8936791A (en) 1992-06-25
EP0513387A1 (de) 1992-11-19
DK0513387T3 (da) 2000-06-05
DK1130017T3 (da) 2005-10-10
CA2074933C (en) 2002-12-03
JPH0551318A (ja) 1993-03-02
KR927003551A (ko) 1992-12-18
HK1003938A1 (en) 1998-11-13
WO1992009586A1 (en) 1992-06-11
JPH10101562A (ja) 1998-04-21
DK0934937T3 (da) 2002-04-02
KR100249545B1 (en) 2000-04-01
DE69132006T2 (de) 2000-08-03
US5643932A (en) 1997-07-01
DE69133471T2 (de) 2006-05-11
CA2074933A1 (en) 1992-05-31
ES2245660T3 (es) 2006-01-16
TW311136B (de) 1997-07-21
CA2396738C (en) 2006-08-29
CA2547947C (en) 2007-09-25
ES2144403T3 (es) 2000-06-16
EP1130017B1 (de) 2005-06-15
USRE37556E1 (en) 2002-02-19
DE69132006D1 (de) 2000-04-06
AU656930B2 (en) 1995-02-23

Similar Documents

Publication Publication Date Title
DE69132944D1 (de) Azolederivate als Inhibitor von Superoxide-Radikalen
DE69226820D1 (de) Peptidylderivate als Inhibitoren von Interleukin-1B-konvertierenden Enzymen
DE69533589D1 (de) Tetra-substituierte phenyl-derivate verwendbar als pde iv hemmer
ATE222240T1 (de) Hiv - protease inhibitoren
FI941519A (fi) Farnesyyliproteiinitransferaasin heterosyklisiä inhibiittoreita
ATE408607T1 (de) Substituierte benzensulfonamid-derivate als wirkstoff-vorläufer von cox-2 inhibitoren
ES2179822T3 (es) Nuevas 4-arilpiperazinas y 4-arilpiperidinas.
DE69315662D1 (de) Aminderivate als Korrosionsinhibitoren
FI971413A (fi) Puriini- ja guaniiniyhdisteet PNP:n estäjinä
DE69233356D1 (de) Carbostyrilderivate als Phosphodiesterase-Hemmstoffe
DE69511240D1 (de) Derivate des hydroxamsäure als metalloproteinaseinhibitoren
DE69728139T2 (de) Pyrrolopyrrolone als inhibitoren von neutrophiler elastase
DE69801878D1 (de) Verwendung von Oxamatderivaten als Depigmentierungsmittel
FI973211A (fi) Ihmisen leukosyyttielastaasin inhibiittoreina hyödylliset proliinijohdannaiset
EE9700093A (et) Apolipoproteiin-B sünteesi inhiibitorid
MX9100998A (es) Novedosos inhibidores de escualen sintetasa
DE69431201D1 (de) Verwendung von indolderivaten als 5ht1-agonisten
DE69629961D1 (de) Inhibierung von Exoproteinen in absorbiereden Produkten
DE69206725D1 (de) Benzolsulfonamidderivate als 5-Lipoxygenasehemmer
NO954323D0 (no) Heterocykliske derivater
NO911999L (no) Anvendelse av substituerte beta-hydroksyetylaminer som potente hemmestoffer til exoenzymer i sopp.
ITMI920084A0 (it) Alchil derivati del trazodone
DE69418676D1 (de) Deprotonierung von Cyclopentadienylderivate
NO914123L (no) Fremgangsmaate for korrosjonsbeskyttelse av j-roer
FI960371A (fi) Tiatsolijohdannaisia lipoksigenaasi-inhibiittoreina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition